Regulation of Chemokine Recognition by Site-Specific Tyrosine Sulfation of Receptor Peptides

Chemistry and Biology

Volumn 16, Issue 2, 2009, Pages 153-161

  Simpson, Levi S ^a   Zhu, John Z ^a   Widlanski, Theodore S ^a   Stone, Martin J ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

CHEMBIO; PROTEINS; SIGNALING

Indexed keywords

CHEMOKINE RECEPTOR CCR3; DRUG DERIVATIVE; EOTAXIN; PEPTIDE; TYROSINE; TYROSINE O-SULFATE; TYROSINE SULFATE;

ARTICLE; BINDING SITE; CHEMISTRY; METABOLISM; PROTEIN BINDING; SYNTHESIS;

BINDING SITES; CHEMOKINE CCL11; PEPTIDES; PROTEIN BINDING; RECEPTORS, CCR3; TYROSINE;

EID: 60549105011     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.12.007     Document Type: Article

References (38)

1. Ando T., Yamataka H., Kuramochi J., Yamawaki J., and Yukawa Y. Neighboring group participation in solvolysis. 6. Methyl participation in acetolysis of neopentyl para-nitrobenzenesulfonate. Tetrahedron Lett. 17 (1976) 1879-1880
2. Bannert N., Craig S., Farzan M., Sogah D., Santo N.V., Choe H., and Sodroski J. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 194 (2001) 1661-1673
3. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996) 1135-1148
4. Choe H., Moore M.J., Owens C.M., Wright P.L., Vasilieva N., Li W., Singh A.P., Shakri R., Chitnis C.E., and Farzan M. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol. Microbiol. 55 (2005) 1413-1422
5. Clubb R.T., Omichinski J.G., Clore G.M., and Gronenborn A.M. Mapping the binding surface of interleukin-8 complexes with an N-terminal fragment of the type 1 human interleukin-8 receptor. FEBS Lett. 338 (1994) 93-97
6. Cormier E.G., Persuh M., Thompson D.A., Lin S.W., Sakmar T.P., Olson W.C., and Dragic T. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 97 (2000) 5762-5767
7. Crump M.P., Rajarathnam K., Kim K.S., Clark-Lewis I., and Sykes B.D. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J. Biol. Chem. 273 (1998) 22471-22479
8. Dawson P.E., Muir T.W., Clarklewis I., and Kent S.B.H. Synthesis of Proteins by Native Chemical Ligation. Science 266 (1994) 776-779
9. Dorfman T., Moore M.J., Guth A.C., Choe H., and Farzan M. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection. J. Biol. Chem. 281 (2006) 28529-28535
10. Duma L., Haussinger D., Rogowski M., Lusso P., and Grzesiek S. Recognition of RANTES by extracellular parts of the CCR5 receptor. J. Mol. Biol. 365 (2007) 1063-1075
11. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., and Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 (1999) 667-676
12. Farzan M., Vasilieva N., Schnitzler C.E., Chung S., Robinson J., Gerard N.P., Gerard C., Choe H., and Sodroski J. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J. Biol. Chem. 275 (2000) 33516-33521
13. Farzan M., Babcock G.J., Vasilieva N., Wright P.L., Kiprilov E., Mirzabekov T., and Choe H. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J. Biol. Chem. 277 (2002) 29484-29489
14. Fong A.M., Alam S.M., Imai T., Haribabu B., and Patel D.D. CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 277 (2002) 19418-19423
15. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385 (1997) 645-649
16. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., et al. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317 (2007) 1930-1934
17. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., Truong O., Hsuan J.J., and Williams T.J. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179 (1994) 881-887
18. Kay L.E.K., Keiffer P., and Saarinen T. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114 (1992) 10663-10665
19. Kehoe J.W., and Bertozzi C.R. Tyrosine sulfation: a modulator of extracellular protein-protein interactions. Chem. Biol. 7 (2000) R57-R61
20. Kitagawa K., Aida C., Fujiwara H., Yagami T., Futaki S., Kogire M., Ida J., and Inoue K. Facile Solid-Phase Synthesis of Sulfated Tyrosine-Containing Peptides. J. Org. Chem. 66 (2001) 1-10
21. Leppanen A., White S.P., Helin J., McEver R.P., and Cummings R.D. Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues. J. Biol. Chem. 275 (2000) 39569-39578
22. Liu J., Louie S., Hsu W., Yu K.M., Nicholas Jr. H.B., and Rosenquist G.L. Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease. Am. J. Respir. Cell Mol. Biol. 38 (2008) 738-743
23. Mayer K.L., and Stone M.J. NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2. Biochemistry 39 (2000) 8382-8395
24. Penke B., and Nyerges L. Solid-phase synthesis of porcine cholecystokinin-33 in a new resin via FMOC-strategy. Pept. Res. 4 (1991) 289-295
25. Preobrazhensky A.A., Dragan S., Kawano T., Gavrilin M.A., Gulina I.V., Chakravarty L., and Kolattukudy P.E. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J. Immunol. 165 (2000) 5295-5303
26. Rankin S.M., Conroy D.M., and Williams T.J. Eotaxin and eosinophil recruitment: implications for human disease. Mol. Med. Today 6 (2000) 20-27
27. Schlienger N., Peyrottes S., Kassem T., Imbach J.L., Gosselin G., Aubertin A.M., and Perigaud C. S-acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs. J. Med. Chem. 43 (2000) 4570-4574
28. Seibert C., Cadene M., Sanfiz A., Chait B.T., and Sakmar T.P. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc. Natl. Acad. Sci. USA 99 (2002) 11031-11036
29. Seibert C., and Sakmar T.P. Toward a framework for sulfoproteomics: Synthesis and characterization of sulfotyrosine-containing peptides. Biopolymers 90 (2008) 459-477
30. Seibert C., Veldkamp C.T., Peterson F.C., Chait B.T., Volkman B.F., and Sakmar T.P. Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. Biochemistry 47 (2008) 11251-11262
31. Simpson L.S., and Widlanski T.S. A comprehensive approach to the synthesis of sulfate esters. J. Am. Chem. Soc. 128 (2006) 1605-1610
32. Skelton N.J., Quan C., Reilly D., and Lowman H. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure 7 (1999) 157-168
33. Veldkamp C.T., Seibert C., Peterson F.C., De la Cruz N.B., Haugner III J.C., Basnet H., Sakmar T.P., and Volkman B.F. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal 1 (2008) ra4
34. Veldkamp C.T., Seibert C., Peterson F.C., Sakmar T.P., and Volkman B.F. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J. Mol. Biol. 359 (2006) 1400-1409
35. Yawalkar N., Uguccioni M., Scharer J., Braunwalder J., Karlen S., Dewald B., Braathen L.R., and Baggiolini M. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J. Invest. Dermatol. 113 (1999) 43-48
36. Ye J., Kohli L.L., and Stone M.J. Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. J. Biol. Chem. 275 (2000) 27250-27257
37. Ye J., Mayer K.L., and Stone M.J. Backbone dynamics of the human CC-chemokine eotaxin. J. Biomol. NMR 15 (1999) 115-124
38. Young T., and Kiessling L.L. A strategy for the synthesis of sulfated peptides. Angew. Chem. Int. Ed. Engl. 41 (2002) 3449-3451